Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bbd0b1062cc7ed1acf530b9d9536fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08fd5336ec3dd22e427176de8f588a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f57b1d8957a0371f0b9fb90d33d75aa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07555d7fb2c286a39191d6b751f8ca3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e96466b68da5b2d5b255cceed80a2d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N23-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88da905b4f8853f8c87b8c1149e0173a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37747af8836bcd2b4708d0fe882a8ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f378f25f54d6d2a39ca1d7dac9076e4 |
publicationDate |
2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8999655-B2 |
titleOfInvention |
Increase of myeloid microvesicles in the cerebrospinal fluid as biomarker of microglia/macrophage activation in neurological disorders |
abstract |
The present invention relates to a method for the diagnostic and/or prognostic of a neurological disease characterized by an inflammation process in a subject comprising measuring the amount of myeloid derived microvesicles in a cerebrospinal fluid sample obtained from the subject. The invention further relates to a method for predicting and/or monitoring the efficacy of a treatment for a neurological pathology or for monitoring a neurological disease progression. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3542159-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4012045-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020500309-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017084770-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017085287-A1 |
priorityDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |